There have been many reports that high soya-based diets reduce the risk of
certain types of cancer. This effect may be due to the presence of high lev
els of isoflavones derived from the soyabean, particularly genistein which
has been shown to be a protein tyrosine kinase (PTK) inhibitor and have bot
h oestrogenic and anti-oestrogenic properties. We have examined the effect
of genistein and a number of novel synthetic analogues on both normal (IEC6
, IEC18) and transformed (SW620, HT29) intestinal epithelial cell lines. Re
sponses were compared to those elicited by oestradiol, the anti-oestrogen t
amoxifen, and the tyrosine kinase inhibitor tyrphostin. Genistein and tamox
ifen were potent inhibitors of cell proliferation. Of seven novel isoflavon
es tested, none were more potent inhibitors than genistein, and all display
ed similar relative activities across the different cell lines. In addition
to inhibiting cell proliferation, cell death via apoptosis was observed wh
en the cells were exposed to the isoflavones and all but one exhibited PTK
inhibitory activity. These data suggest that by reducing proliferation and
inducing apoptosis, possibly due in part to PTK inhibition, isoflavones may
have a role in protecting normal intestinal epithelium from tumour develop
ment (reducing the risk) and may reduce colonic tumour growth.